Intraday and Recent Price Movements
On the day of the new low, Borosil Scientific opened with a gap down of 5.72%, touching an intraday low of Rs.97.25, which also represents its 52-week low. Despite a slight outperformance relative to its sector, which fell by 3.89%, the stock closed with a loss of 2.62%. This decline followed two consecutive days of gains, signalling a reversal in short-term momentum.
The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, underscoring the sustained bearish trend. Comparatively, the Sensex declined by 2.92% on the same day, indicating that Borosil Scientific’s drop was in line with broader market weakness but still notable given its fresh low.
Performance Metrics Over Various Timeframes
Examining the stock’s performance over multiple periods reveals a consistent underperformance relative to the Sensex benchmark. Over the past one day, the stock fell by 2.62% versus the Sensex’s 2.92% decline. Over one week, Borosil Scientific declined by 2.76%, outperforming the Sensex’s 4.52% fall. However, over one month, the stock’s loss widened to 5.64%, while the Sensex dropped 8.86%.
More concerning is the three-month performance, where the stock plunged 19.77%, more than double the Sensex’s 9.51% decline. Over the last year, Borosil Scientific’s share price has fallen 22.82%, contrasting sharply with the Sensex’s 3.07% gain. Year-to-date, the stock is down 16.33%, compared to the Sensex’s 10.10% decline. Notably, the stock has delivered no gains over the past three and five years, while the Sensex has appreciated by 28.10% and 50.15% respectively. Over a decade, the stock’s return remains flat, whereas the Sensex surged 209.00%.
Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.
- - Market-beating performance
- - Committee-backed winner
- - Aluminium & Aluminium Products standout
Financial and Valuation Analysis
Borosil Scientific’s financial metrics highlight several areas of concern. The company’s average Return on Equity (ROE) stands at a modest 4.53%, indicating limited profitability relative to shareholders’ funds. This low ROE is a key factor behind the stock’s current Sell rating, as per its Mojo Grade of 37.0, which was downgraded from Strong Sell on 11 February 2026.
Over the past five years, the company’s net sales have grown at an annual rate of 9.80%, while operating profit has increased at a much slower pace of 2.86%. This disparity suggests challenges in converting revenue growth into meaningful profit expansion. Despite this, the company’s profits rose by 11% over the last year, even as the stock price declined by 22.82%, reflecting a disconnect between earnings and market valuation.
The stock currently trades at a Price to Book Value ratio of 2.3, which is considered expensive given the company’s low ROE and subdued growth rates. However, this valuation is at a discount compared to its peers’ historical averages, indicating some relative value in the context of the sector.
Shareholding and Market Capitalisation Insights
Despite Borosil Scientific’s sizeable market presence, domestic mutual funds hold a minimal stake of just 0.04%. Given that mutual funds typically conduct thorough research before investing, this limited exposure may reflect reservations about the company’s current valuation or business prospects. The company’s Market Cap Grade is rated 4, suggesting a moderate market capitalisation relative to its sector peers.
On the debt front, Borosil Scientific maintains a low average Debt to Equity ratio of zero, indicating a debt-free balance sheet. This conservative capital structure reduces financial risk but has not translated into improved market performance.
Recent Quarterly Performance Highlights
In the December 2025 quarter, Borosil Scientific reported positive results following two consecutive quarters of negative performance. The company achieved its highest quarterly PBDIT at Rs.17.19 crores and an operating profit to net sales ratio of 14.17%. Additionally, Profit Before Tax excluding other income reached Rs.12.15 crores, marking the best quarterly figure in recent periods. These results demonstrate some operational improvement, though the stock price has yet to reflect this progress.
Borosil Scientific Ltd or something better? Our SwitchER feature analyzes this micro-cap Industrial Products stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Market Context
Borosil Scientific operates within the Industrial Products sector, specifically the glass segment, which has experienced a decline of 3.89% recently. The stock’s performance has generally mirrored sector trends but has underperformed the broader market indices over longer periods. The Sensex’s positive returns over one year and beyond contrast with Borosil Scientific’s flat or negative returns, highlighting the stock’s relative weakness.
The company’s Mojo Score of 37.0 and Sell grade reflect the cumulative impact of its financial performance, valuation, and market sentiment. The downgrade from Strong Sell to Sell in February 2026 indicates a slight improvement in outlook, though the overall assessment remains cautious.
Summary of Key Challenges
Borosil Scientific’s share price decline to an all-time low is underpinned by several factors: subdued profitability as evidenced by a low ROE, slow growth in operating profit despite moderate sales expansion, and valuation concerns given its price-to-book ratio. The stock’s underperformance relative to the Sensex and sector peers over multiple timeframes further emphasises the challenges faced by the company in delivering shareholder value.
While recent quarterly results show some improvement in profitability metrics, the broader market has yet to respond positively. The limited interest from domestic mutual funds also suggests a cautious stance among institutional investors.
Conclusion
Borosil Scientific Ltd’s fall to Rs.97.25 marks a significant point in its share price trajectory, reflecting persistent pressures in its financial and market performance. The stock’s position below all major moving averages and its relative underperformance over short and long-term periods highlight the severity of the current situation. Investors and market participants will continue to monitor the company’s financial disclosures and sector developments closely as the stock navigates this challenging phase.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
